Stoke Therapeutics, Inc. (STOK)

NASDAQ

$26.33

$-0.02

(-0.06%)

Regular Market

Stoke Therapeutics, Inc. (STOK) Live Price Chart

Last updated: ⁦2026-10-21 16:04:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Stoke Therapeutics, Inc. (STOK) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $26.33, with a market capitalization of $1.60B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $20.32 to $40.22. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.60B
Open	$26.83
Day's High	$71.58
Day's Low	$3.35
Previous Close	$26.61
Volume	307.61K
Average Volume	916.10K
P/E Ratio	--
52-Week High	$40.22
52-Week Low	$20.32
Dividend Yield	--
Earnings Date	--

Stoke Therapeutics, Inc. (STOK) Stock Price Today

Stoke Therapeutics, Inc. (STOK) is currently trading at $26.33 as of 2026-10-21 15:48:04, down 1.05% ($0.28) from the previous close of $26.61

During today's regular trading session, STOK has traded between $3.35 and $71.58, with a trading volume of 307.61K shares. The current price is near the middle of today's range.

Stoke Therapeutics, Inc. (STOK) 7-Day Stock Price Change

Over the past seven days, Stoke Therapeutics, Inc. (STOK) moved from $24.15 to $26.33, representing a gain of 9.03% ($2.18).

The stock traded between $22.05 and $27.22 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 992.68 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

STOK 52-Week Price Position

Position in Range: 30.2%

52W Low$20.32

52W High$40.22

STOK is currently trading at $26.33, placing it 30.2% of the way from its 52-week low of $20.32 to its 52-week high of $40.22. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Stoke Therapeutics, Inc. (STOK)?

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Stoke Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	170
Exchange	NASDAQ
Company Website	https://www.stoketherapeutics.com

How to Buy Stoke Therapeutics, Inc. (STOK) Stock on MEXC

Eligible investors can buy real shares of Stoke Therapeutics, Inc. (STOK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for STOK and Place Your Order

Open the RealStocks trading page and search for STOK. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Stoke Therapeutics, Inc. (STOK) stock price today?

Stoke Therapeutics, Inc. (STOK) is currently trading at $ 26.33, down 1.05% ($0.28) from the previous close of $ 26.61. Intraday prices update in real time during regular trading hours.

2.Is STOK stock going up or down today?

As of 2026-10-21 15:48:04, STOK is trading at $ 26.33, down 1.05% ($0.28) from its previous close of $ 26.61. The stock has traded between $ 3.35 and $ 71.58 during today’s regular session. Past price movements do not guarantee future results.

3.What is STOK pre-market price?

As of 2026-10-21 15:48:04, STOK is trading at $ 26.99 in pre-market trading, up 1.42% ($0.38) from the previous close of $ 26.61. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is STOK after-hours price?

As of 2026-10-21 15:48:04, STOK is trading at $ 26.69 in after-hours trading, up 0.30% ($0.08) from the regular-session close of $ 26.61. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is STOK stock trading now?

STOK trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does STOK sit relative to its 52-week high and low?

Over the past 52 weeks, STOK has traded between a low of $ 20.32 and a high of $ 40.22. At $ 26.33, the stock is positioned 30.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Stoke Therapeutics, Inc. in?

Stoke Therapeutics, Inc. (STOK) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Stoke Therapeutics, Inc.'s market capitalization and where is it listed?

Stoke Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 1.60B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is STOK valued in terms of P/E ratio and EPS?

STOK trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.22. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Stoke Therapeutics, Inc. pay a dividend?

Stoke Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.